Identification of HDAC Inhibitors Using a Cell-Based HDAC I/II Assay
2016 · SLAS DISCOVERY · 32 citations
https://doi.org/10.1177/1087057116629381
S
Sheng Dai
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
75
Papers
734
Citations
17
h-index
20
i10-index
Sheng Dai is an academic researcher from Fujian Medical University. The author has contributed to research in topics: Autophagy in Disease and Therapy & Lysosomal Storage Disorders Research & Genetic factors in colorectal cancer. The author has an h-index of 17, co-authored 64 publications.
ORCID: 0000-0002-5387-8517Papers by this author
worksBilirubin ameliorates osteoarthritis via activating Nrf2/HO‐1 pathway and suppressing NF‐κB signalling
2024 · Journal of Cellular and Molecular Medicine · 28 citations
https://doi.org/10.1111/jcmm.18173
Pyrvinium pamoate inhibits cell proliferation through ROS-mediated AKT-dependent signaling pathway in colorectal cancer
2021 · Medical Oncology · 17 citations
https://doi.org/10.1007/s12032-021-01472-3
Efficacy and safety of combining short-course neoadjuvant chemoradiotherapy with envafolimab in locally advanced rectal cancer patients with microsatellite stability: a phase II PRECAM experimental study
2024 · International Journal of Surgery · 15 citations
https://doi.org/10.1097/js9.0000000000001960
Targeting macrophage polarization with opsonized bilirubin/melatonin nanoparticles: A biomimetic approach for acute lung injury
2025 · Colloids and Surfaces B Biointerfaces · 3 citations
https://doi.org/10.1016/j.colsurfb.2025.115237
Risk factors for incomplete polyp resection during colonoscopy
2021 · Laparoscopic Endoscopic and Robotic Surgery · 0 citations
https://doi.org/10.1016/j.lers.2021.09.004
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat